Mounjaro 2.5mg Kwikpen contains tirzepatide as its active ingredient and is a continuous-acting dual receptor agonist, which is a combination of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). It mimics both the hormones and functions with their receptors to regulate sugar levels and reduce appetite. It binds to receptors in the brain and decreases appetite by slowing the movement of food through the body. It binds to beta cells in the pancreas and boosts the secretion of insulin in a glucose-dependent manner, thereby improving sensitivity to insulin. It limits the production of glucagon in the intestines when the blood sugar levels are high. This self-injectable pen is prescribed to adults suffering from type 2 diabetes and have a body mass index of 27 or higher, helping in controlling blood sugar levels and managing weight.

The health and medical information provided here is for general purposes only and is not a substitute for the expertise and judgment of your physician, or other health care professional. It should not be understood to indicate that the use of this medicine is safe, appropriate or effective for you. Always consult your health care professional before using this, or any other, drug.

• This medication is not suitable for you if you have a personal or family history of medullary carcinoma (a rare thyroid cancer).
• It is not considered safe to be used during the course of pregnancy as it can put the health of the unborn child at risk. Stop its use 2 months before conception.
• Before the doctor prescribes you Mounjaro Kwikpen, tell them about all the medications you are already on so that they can decide whether it is safe to consume it in combination.
• Do not use this pen if you are allergic to tirzepatide or any other ingredient mentioned on the label of the product.
• Restrain yourself from alcohol consumption, as it can cause high blood pressure and dizziness when you are diabetic.
• Take the exact dosage of this medication recommended by your doctor and do not increase or decrease it without consulting your doctor.

Common side effects of administering this medicine include nausea, abdominal pain, vomiting, diarrhea, bloating of the stomach, headache, fatigue, and constipation. Most of these are related to the stomach because of the delayed gastric emptying and usually go away after the first few weeks as the body adjusts to the medication.
There is a rare chance of you experiencing some serious side effects. Contact your doctor immediately if you feel that the common effects are consistent and have started to become unbearable. Serious side effects include constant pain in the gall bladder, damage to the kidneys, inflammation of the pancreas or pancreatitis, low blood sugar levels or hypoglycemia, and blurred vision or worsening of the eyesight.

• Mounjaro 2.5mg Kwikpen is an easy-to-use pen that is administered once a week, repeated every week on the same day of the week.
• Inspect the pre-filled pen before using and make sure that it is not damaged.
• It is a multi-dose pen; remove the inner seal, push the capped needle, and tighten it. Change the needle every single time before using.
• Align the extended line on the dose indicator with “0” by slowly turning the knob.
• This medication is self-injectable and should be injected into the skin on areas such as the upper arms, the front part of the thighs, or the lower abdomen.
• After administering the pen, keep the pen still and hold the dose button for 5 seconds. Wait till the dose indicator turns back to zero.